Monthly Archives: October 2020

SEATTLE, Oct. 15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312. Led by founder and CEO Dr. Connie Wan, SGC redefines a household staple […]